Avesh Thuluvath, MD
Transplant Hepatology · New York, NYNPI 1417348285
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $702 of the $801 with a category attached, or 87.6%. 8 manufacturers reported payments, led by Salix Pharmaceuticals, A Division Of Bausch Health US, LLC at 28.4% of the total. Reporting peaked in 2021 at $345 and has fallen 76.2% since, to $82 in 2025. That places this record below the midpoint for transplant hepatology clinicians in NY, where the typical reported total is $1,622.
Across 16 payments — averaging $50.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$227
- Johnson & Johnson$127
- Janssen Scientific Affairs, LLC$111
- Gilead$109
- AbbVie$104
- Ipsen Biopharmaceuticals, Inc$58
- plus $65 from 2 others
What the payments were for
- Food & beverage$70288%
- Education$9912%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 6 | $227 |
| Johnson & Johnson | 2 | $127 |
| Janssen Scientific Affairs, LLC | 1 | $111 |
| Gilead | 2 | $109 |
| AbbVie | 1 | $104 |
| Ipsen Biopharmaceuticals, Inc | 2 | $58 |
| Madrigal Pharmaceuticals | 1 | $49 |
| Cumberland Pharmaceuticals, Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$801 in reported general payments places this provider in the 35th percentile of 36 transplant hepatology providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other transplant hepatology in New York
- Nikolaos PyrsopoulosNew York$251K
- James ParkNew York$81K
- Amon AsgharpourNew York$58K
- Giuseppe CullaroNew York$50K
- Julia WattacherilNew York$37K
- Gene ImNew York$15K
- Elizabeth VernaNew York$11K
- Rajani SharmaNew York$11K
- Annmarie LiapakisNew York$10K
- Alyson FoxNew York$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.